Benzinga | Aug 12, 2021 07:12AM EDT

Werewolf Therapeutics Q2 EPS $(3.82) Down From $0.22 YoY

Werewolf Therapeutics (NASDAQ:HOWL) reported quarterly losses of $(3.82) per share. This is a 1836.36 percent decrease over earnings of $0.22 per share from the same period last year.